BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26016749)

  • 1. Immunosuppressive treatment for giant cell arteritis: where do we stand?
    Pipitone N; Salvarani C
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-5-6. PubMed ID: 26016749
    [No Abstract]   [Full Text] [Related]  

  • 2. Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?
    Salvarani C; Pipitone N; Boiardi L; Hunder GG
    Ann Rheum Dis; 2008 May; 67(5):577-9. PubMed ID: 18408108
    [No Abstract]   [Full Text] [Related]  

  • 3. Giant Cell Arteritis: 2018 Review.
    Winkler A; True D
    Mo Med; 2018; 115(5):468-470. PubMed ID: 30385998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving therapeutic options for patients with giant cell arteritis.
    Pipitone N; Salvarani C
    Curr Opin Rheumatol; 2008 Jan; 20(1):17-22. PubMed ID: 18281852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs.
    Airò P; Antonioli CM; Vianelli M; Toniati P
    Rheumatology (Oxford); 2002 Mar; 41(3):347-9. PubMed ID: 11934977
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index.
    Berti A; Cornec D; Medina Inojosa JR; Matteson EL; Murad MH
    Semin Arthritis Rheum; 2018 Aug; 48(1):77-82. PubMed ID: 29496228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Temporal arteritis: treatment controversies].
    Balsalobre Aznar J; Porta-Etessam J
    Neurologia; 2010 Sep; 25(7):453-8. PubMed ID: 20964992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
    Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
    J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?].
    Samson M; Bonnotte B
    Rev Med Interne; 2018 Feb; 39(2):75-77. PubMed ID: 29217104
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of tocilizumab in refractory giant cell arteritis.
    Vinit J; Bielefeld P; Muller G; Besancenot JF
    Joint Bone Spine; 2012 May; 79(3):317-8. PubMed ID: 22284606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating an underdiagnosed cause of headaches.
    Johns Hopkins Med Lett Health After 50; 1998 Apr; 10(2):6. PubMed ID: 9552804
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of large-vessel vasculitis: where do we stand?
    Salvarani C; Pipitone N
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S3-5. PubMed ID: 21586197
    [No Abstract]   [Full Text] [Related]  

  • 15. Are steroids alone sufficient for the treatment of giant cell arteritis?
    Pipitone N; Boiardi L; Salvarani C
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):277-92. PubMed ID: 15857796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone.
    Carbonella A; Berardi G; Petricca L; Biscetti F; Alivernini S; Bosello SL; Fedele AL; Ferraccioli G; Gremese E
    J Am Geriatr Soc; 2016 Mar; 64(3):672-374. PubMed ID: 27000356
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of giant cell arteritis].
    Sailler L; Pugnet G; Bienvenu B
    Rev Med Interne; 2013 Jul; 34(7):431-7. PubMed ID: 23562185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for giant cell arteritis: an amazing result.
    Işık M; Kılıç L; Doğan İ; Calgüneri M
    Rheumatol Int; 2013 Nov; 33(11):2961-2. PubMed ID: 22965672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate in giant-cell arteritis.
    Spiera RF; Paget S; Spiera H
    Ann Intern Med; 2001 Dec; 135(11):1006-7. PubMed ID: 11730407
    [No Abstract]   [Full Text] [Related]  

  • 20. Giant cell arteritis--the methotrexate debate revisited.
    Rimar D; Rozenbaum M; Zisman D; Boulman N; Slobodin G; Eder L; Feld J; Rosner I
    J Rheumatol; 2006 Jul; 33(7):1458-9. PubMed ID: 16862661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.